<DOC>
	<DOCNO>NCT01115426</DOCNO>
	<brief_summary>This study evaluate prospectively effect anti-angiotensin II regimen renal outcome patient mesangioproliferative glomerulonephritis followed-up 10 year .</brief_summary>
	<brief_title>Inhibitors Angiotensin II Proteinuric Mesangioproliferative Glomerulonephritis</brief_title>
	<detailed_description>After sign informed consent , enrol patient start treatment ACEi . We decide prescribe patient drug ( ramipril ) dosage ( 5 mg/day ) . All patient examine every 2 month first year follow-up every 6 month thereafter . At visit , underwent complete physical examination . If target blood pressure &lt; 140/90 mmHg achieve ramipril monotherapy , addition antihypertensive drug ( ) allow . Patients complain adverse side effect attribute ramipril switch losartan ( 50 mg/day ) . The patient also prescribe normal protein ( 1 gram/kg/day ) moderately salt-restricted ( 6-8 grams/day ) diet throughout study .</detailed_description>
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<criteria>proteinuria â‰¥ 1 g &lt; 3 g/24 hour stable 3 month runin microscopic hematuria ( least 10 red blood cell per highpower field ) , without sign symptom systemic disease stable 3 month runin noevidence renal failure relevant diseases biopsy diagnosis III stage IgA pauciimmuneMsPGN estimate Glomerular Filtration Rate ( eGFR ) &lt; 80 ml/min/1.73m2 previous immunosuppressive treatment blood pressure ( BP ) &gt; 150/90 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 1997</verification_date>
</DOC>